Novo Nordisk said on Tuesday the European Commission has approved a higher dose of its popular obesity drug Wegovy, providing patients and doctors with an option that may support greater weight loss.

I’ve said it before, and I’ll say it again: everyone should have a pen in their everyday carry loadout. Yes, even in the digital age, they come in handy much more often than you might think. That said ...

Novo Nordisk (NVO) on Wednesday announced plans to launch some doses of its oral GLP-1 receptor agonist semaglutide under the brand name Ozempic pill in Q2 2026, following a successful commercial ...

Shares in Danish pharmaceuticals group Novo Nordisk plunged Wednesday after the maker of Ozempic and Wegovy anti-obesity drugs warned of lower sales this year in the key US market. The Barron's news ...

Shares in Danish pharmaceuticals group Novo Nordisk plunged Wednesday after the maker of Ozempic and Wegovy anti-obesity drugs warned of lower sales this year in the key US market. In afternoon ...

Silver tumbles 12% in 3 days to Rs 1.66 lakh, gold down Rs 9,000/10 gm. Should you hit sell? Madhavan quit acting for 4 years after he felt humiliated by Swiss farmer: ‘I travelled across India, spoke ...

Weight loss injections have rapidly shifted from niche medical treatments to mainstream conversation, but the term ‘Ozempic neck’ is starting to become part of discussions more often, too. Drugs such ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose some weight. Reading time 5 minutes The arrival of semaglutide and similar ...

Getting your Trinity Audio player ready... Low energy. “Ozempic face.” Feeling like a deflated balloon. They can be the downsides for people on GLP-1s, the increasingly popular drugs that go by the ...

Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find inspiration for its latest direct-to-consumer Ozempic campaign. The new ads hark ...